In a world where antibiotic resistance is on the rise, phage therapy is once again gaining attention as a promising alternative to traditional treatments. But could bacteria become resistant to bacteriophages? And if so, what implications would this have for medicine?

Phages vs. Bacteria: A Long-Run Evolutionary Race

Bacteriophages and bacteria have coexisted for billions of years—a classic example of an evolutionary race: as soon as bacteria find a way to avoid infection by phages, the latter evolve and learn to bypass these defenses. Bacteria can develop resistance to bacteriophages through several mechanisms. Most commonly, through mutations that alter or block receptors on the cell surface through which the phage enters. Some bacteria activate systems that destroy viral DNA after penetration. Of particular interest is the CRISPR -Cas system, which effectively constitutes adaptive immunity in bacteria against viruses. But each such defense comes at a cost.

Is phage resistance really that scary?

The answer is both yes and no. Yes, bacteria can indeed become resistant to phages. But unlike antibiotics, to which bacteria develop stable resistance, resistance to bacteriophages is often accompanied by a decrease in bacterial viability. If a phage attacks a cell through a specific protein receptor, the bacterium can modify this protein to "hide." But if this protein is important for nutrient absorption or tissue attachment, such a mutation makes the bacterium less aggressive or even inviable. As a result, even phage-resistant bacteria often lose their pathogenicity and, in some cases, become more sensitive to antibiotics.

How to prevent phage resistance?

Fortunately, phage therapy has several strategies to combat the potential development of resistance:

1. Phage cocktails. Using several different bacteriophages simultaneously is the most common approach. For a bacterium to become insensitive to all phages in a cocktail, it would have to mutate at several points simultaneously, which is extremely unlikely.
2. Personalized phage therapy. In some cases, doctors select bacteriophages individually for each patient based on the pathogen's susceptibility, which is particularly effective in treating chronic or nosocomial infections.
3. Combination with antibiotics. Some studies suggest that the combined use of phages and antibiotics may reduce the risk of developing resistance and enhance treatment effectiveness.
4. Modified phages. Using biotechnology, scientists have already learned to genetically modify bacteriophages. These "improved" viruses not only destroy bacteria but can also deliver genes that suppress bacterial defense mechanisms.

Phage therapy is not a magic wand, but it is a powerful tool.

Bacteriophages target only specific types of bacteria without affecting beneficial microflora, making them non-toxic and safer for the body. This is especially important in pediatrics, during long-term treatment, and for patients with weakened immune systems. Phage therapy does not compete with antibiotics, but rather complements them.

Yes, there is a risk of phage effectiveness being reduced, but unlike antibiotics, phages are dynamic and renewing. They quickly adapt and evolve along with their target. In nature, this process occurs continuously, so we will always have a wide range of therapeutic options. The future of medicine lies in adaptive approaches. In countries where phage therapy is actively developing (Georgia, Poland, France, Israel), patients who have failed antibiotics are already being saved. And while science continues to search for answers, the future looks promising: bacteria may become resistant to individual phages, but this is a challenge for which modern biomedicine already has an answer.